Morgan Stanley Lowers Illumina (NASDAQ:ILMN) Price Target to $100.00
Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Morgan Stanley from $136.00 to $100.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the life sciences company’s stock. Morgan Stanley’s price objective would suggest a potential upside of 24.53% from the stock’s current […]
Illumina (NASDAQ:ILMN – Get Free Report) had its price target dropped by Morgan Stanley from $136.00 to $100.00 in a research report issued on Monday,Benzinga reports. The firm currently has an “equal weight” rating on the life sciences company’s stock. Morgan Stanley’s price objective would suggest a potential upside of 24.53% from the stock’s current […]
